Lipocine (LPCN) Quick Ratio: History & Chart

Lipocine Inc.(LPCN)

Biotechnology · Salt Lake City, UT

$2.09+0.02 (+0.72%)

Delayed quote: Oct 6, 2026, 12:22 PM EDT

About Lipocine Inc.

Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic conditions. A core aspect of the company's research and development involves formulating oral delivery methods for pharmaceutical compounds that typically suffer from low bioavailability. Its foremost investigational therapy is TLANDO, an oral solution for testosterone replacement. The company's development pipeline also encompasses several other promising candidates: LPCN 1144: An orally administered prodrug derived from bioidentical testosterone, which has successfully completed Phase II clinical trials for the treatment of non-cirrhotic non-alcoholic steatohepatitis. LPCN 1111: An oral prodrug of testosterone tridecanoate, engineered for once-daily administration, and having also concluded Phase II clinical studies in men experiencing hypogonadism. LPCN 1148: A novel prodrug combining testosterone and testosterone laurate, designed for the management of decompensated cirrhosis. LPCN 1154: An investigational new drug application has been submitted to initiate a Phase 2 study targeting Postpartum Depression. LPCN 2101: A compound intended for women with epilepsy, which has progressed beyond its pre-clinical study phase. LPCN 1107: An oral hydroxyprogesterone caproate product, which has completed its dose-finding Phase II clinical trial aimed at preventing recurrent preterm birth. The corporate headquarters for Lipocine Inc. are located in Salt Lake City, Utah.

Salt Lake City, UT

14 employees

www.lipocine.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Mahesh V. Patel

View full financials

LPCN Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

11.48

QUICK RATIO (ACID-TEST) AVG TTM

9.82

QUICK RATIO (ACID-TEST) AVG 3Y

12.04

QUICK RATIO (ACID-TEST) AVG 5Y

12.91

QUICK RATIO (ACID-TEST) AVG 10Y

10.47

QUICK RATIO (ACID-TEST) AVG 15Y

11.41

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+16.88%

CURRENT VS 3Y AVG

-4.66%

CURRENT VS 5Y AVG

-11.08%

CURRENT VS 10Y AVG

+9.67%

CURRENT VS 15Y AVG

+0.57%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.20

median of 756 covered companies

CURRENT VS SECTOR MEDIAN

+259.26%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Lipocine Inc. (LPCN)	$17.19M	11.48	9.82	12.04	12.91
Marker Therapeutics, Inc. (MRKR)vs ›	$17.01M	6.03	7.38	5.70	5.02
PAVmed Inc. (PAVM)vs ›	$17.17M	1.19	0.11	0.43	2.24
Palatin Technologies, Inc. (PTN)vs ›	$16.76M	4.61	2.49	1.75	2.54
Bionano Genomics, Inc. (BNGO)vs ›	$16.75M	1.96	1.25	1.80	4.00
Cosmos Health Inc. (COSM)vs ›	$17.81M	0.92	0.83	1.35	1.29
Dyadic International, Inc. (DYAI)vs ›	$16.48M	1.65	3.34	3.94	7.05
BioCardia, Inc. (BCDA)vs ›	$16.00M	2.09	1.13	1.21	2.30
Estrella Immunopharma, Inc. (ESLA)vs ›	$18.60M	0.20	0.34	6.34	6.11
Allarity Therapeutics, Inc. (ALLR)vs ›	$15.60M	1.11	2.09	1.19	1.02

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Lipocine Inc. (LPCN)

$17.19M

11.48

9.82

12.04

12.91

Marker Therapeutics, Inc. (MRKR)vs ›

$17.01M

6.03

7.38

5.70

5.02

PAVmed Inc. (PAVM)vs ›

$17.17M

1.19

0.11

0.43

2.24

Palatin Technologies, Inc. (PTN)vs ›

$16.76M

4.61

2.49

1.75

2.54

Bionano Genomics, Inc. (BNGO)vs ›

$16.75M

1.96

1.25

1.80

4.00

Cosmos Health Inc. (COSM)vs ›

$17.81M

0.92

0.83

1.35

1.29

Dyadic International, Inc. (DYAI)vs ›

$16.48M

1.65

3.34

3.94

7.05

BioCardia, Inc. (BCDA)vs ›

$16.00M

2.09

1.13

1.21

2.30

Estrella Immunopharma, Inc. (ESLA)vs ›

$18.60M

0.20

0.34

6.34

6.11

Allarity Therapeutics, Inc. (ALLR)vs ›

$15.60M

1.11

2.09

1.19

1.02

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Lipocine Inc. (LPCN)?

The quick ratio (acid-test) for LPCN stock is 11.48.

Is Lipocine Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 11.48 is 11% below its 5-year average of 12.91, around the middle of its 5-year range (5.35–23.89).

What is the TTM average quick ratio (acid-test) for Lipocine Inc. (LPCN)?

The TTM average quick ratio (acid-test) for LPCN stock is 9.82.

What is the 3Y average quick ratio (acid-test) for Lipocine Inc. (LPCN)?

The 3Y average quick ratio (acid-test) for LPCN stock is 12.04.

What is the 5Y average quick ratio (acid-test) for Lipocine Inc. (LPCN)?

The 5Y average quick ratio (acid-test) for LPCN stock is 12.91.

What is the 10Y average quick ratio (acid-test) for Lipocine Inc. (LPCN)?

The 10Y average quick ratio (acid-test) for LPCN stock is 10.47.

What is the 15Y average quick ratio (acid-test) for Lipocine Inc. (LPCN)?

The 15Y average quick ratio (acid-test) for LPCN stock is 11.41.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	11.48
2026-03-31	9.99
2025-12-31	6.68
2025-09-30	8.25
2025-06-30	12.71
2025-03-31	15.64
2024-12-31	14.75
2024-09-30	12.97
2024-06-30	12.56
2024-03-31	16.99
2023-12-31	8.69
2023-09-30	10.98
2023-06-30	14.82
2023-03-31	15.86
2022-12-31	20.34
2022-09-30	23.89
2022-06-30	22.23
2022-03-31	12.36
2021-12-31	8.26
2021-09-30	6.28
2021-06-30	5.35
2021-03-31	8.51
2020-12-31	3.85
2020-09-30	4.27
2020-06-30	5.54
2020-03-31	5.16
2019-12-31	3.95
2019-09-30	3.31
2019-06-30	4.42
2019-03-31	5.37
2018-12-31	4.63
2018-09-30	7.37
2018-06-30	8.88
2018-03-31	5.03
2017-12-31	3.97
2017-09-30	10.52
2017-06-30	9.63
2017-03-31	11.55
2016-12-31	20.52
2016-09-30	18.71
2016-06-30	12.84
2016-03-31	12.90
2015-12-31	13.23
2015-09-30	19.41
2015-06-30	26.52
2015-03-31	18.66
2014-12-31	17.08
2014-09-30	15.53
2014-06-30	21.22
2014-03-31	28.02
2013-12-31	35.86
2013-09-30	22.78
2013-06-30	0.00
2013-03-31	28.53
2012-12-31	0.05
2012-09-30	0.09
2012-06-30	0.83
2012-03-31	3.72
2011-12-31	4.27

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

11.48

2026-03-31

9.99

2025-12-31

6.68

2025-09-30

8.25

2025-06-30

12.71

2025-03-31

15.64

2024-12-31

14.75

2024-09-30

12.97

2024-06-30

12.56

2024-03-31

16.99

2023-12-31

8.69

2023-09-30

10.98

2023-06-30

14.82

2023-03-31

15.86

2022-12-31

20.34

2022-09-30

23.89

2022-06-30

22.23

2022-03-31

12.36

2021-12-31

8.26

2021-09-30

6.28

2021-06-30

5.35

2021-03-31

8.51

2020-12-31

3.85

2020-09-30

4.27

2020-06-30

5.54

2020-03-31

5.16

2019-12-31

3.95

2019-09-30

3.31

2019-06-30

4.42

2019-03-31

5.37

2018-12-31

4.63

2018-09-30

7.37

2018-06-30

8.88

2018-03-31

5.03

2017-12-31

3.97

2017-09-30

10.52

2017-06-30

9.63

2017-03-31

11.55

2016-12-31

20.52

2016-09-30

18.71

2016-06-30

12.84

2016-03-31

12.90

2015-12-31

13.23

2015-09-30

19.41

2015-06-30

26.52

2015-03-31

18.66

2014-12-31

17.08

2014-09-30

15.53

2014-06-30

21.22

2014-03-31

28.02

2013-12-31

35.86

2013-09-30

22.78

2013-06-30

0.00

2013-03-31

28.53

2012-12-31

0.05

2012-09-30

0.09

2012-06-30

0.83

2012-03-31

3.72

2011-12-31

4.27

Quick Ratio (Acid-Test): 11.48

LPCN Quick Ratio

LPCN Average Quick Ratio (Acid-Test) Chart

LPCN Current vs Average Quick Ratio (Acid-Test) Chart

LPCN Quick Ratio (Acid-Test) Metrics

LPCN Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

LPCN Quick Ratio (Acid-Test) History

Related Metrics